Buchi J Kevin
SEC-identified person · CIK 1209726 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Benitec Biopharma Inc. BNTC | Director | filed 2020 - 2026 |
| Amneal Pharmaceuticals, Inc. AMRX | Director | filed 2018 - 2026 |
| Ampio Pharmaceuticals, Inc. AMPE | Director | filed 2021 - 2023 |
| Dicerna Pharmaceuticals Inc DRNA | Director | filed 2018 - 2021 |
| Ziopharm Oncology INC ZIOP | Director | filed 2020 - 2021 |
| Biospecifics Technologies Corp [BSTC.NGM] | Director · Chief Executive Officer | filed 2019 - 2019 |
| Impax Laboratories, LLC IPXL.OB | Director | filed 2016 - 2018 |
| Alexza Pharmaceuticals Inc. ALXA | Director | filed 2013 - 2016 |
| Stemline Therapeutics INC STML | Director | filed 2013 - 2015 |
| Zalicus Inc. ZLCS | Director | filed 2014 - 2015 |
| Tetralogic Pharmaceuticals Corp TLOG | Director · President and CEO | filed 2013 - 2015 |
| Cephalon INC CEPH | Director · Sr. Vice President and CFO | filed 2006 - 2011 |
| Encysive Pharmaceuticals INC ENCY | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.